Albert David Ltd (ALBERTDAVD) is currently trading at 756.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Albert David Limited is a Kolkata-headquartered pharmaceutical manufacturer producing allopathic and herbal formulations, IV infusion solutions (glass and polyethylene), bulk drugs, and medical disposables, with Placentrex production positioned as a core, long-standing specialty product for both domestic and export markets. The company reported Q2 FY2026 revenue from operations of Rs. 8,724.13 lakhs with a quarter-level operating loss driven by a sharp sequential drop in other income; however the half-year PBT remains positive at Rs. 585.62 lakhs, indicating mixed operational performance masked by volatile non-operating items. Balance sheet dynamics show rising total assets at Rs. 53,294.06 lakhs and a material increase in current borrowings to Rs. 3,951.78 lakhs from Rs. 1,004.92 lakhs year‑end, which financed working capital and capex while operating cash flow remained negative for the half year at Rs. (2,084.59) lakhs. Strategically, Albert David Limited scaled Placentrex manufacturing to handle over 91 lakh units in 2026 and advanced biotechnology work with IIT‑Kharagpur to map active nucleotides and peptides, signaling a transition from legacy natural extract manufacturing toward IP-led biologically characterized products and potential new commercial avenues.

Over the past 52 weeks, Albert David Ltd has traded between a low of ₹581.30 and a high of ₹925.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Albert David Ltd has a market capitalization of approximately 431.68. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Albert David Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.13 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 431.68 Cr, Albert David Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Albert David Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Albert David Ltd is 19.13. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.